Breast Cancer Canada and Astra Zeneca: Screening and Detection Research Grants
Research Admin Offices:
- ROADS
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $100,000 and up to $50,000 of Illumina products in-kind.
Disciplines:
- Health Sciences
Sponsors:
- Breast Cancer Canada
Deadlines:
Internal Deadline:
July 31, 2023Sponsor Deadline:
July 31, 2023Additional Dates:
- LOI HRS & ROADS Due Date: ASAP -
- LOI Sponsor Due Date - July 31, 2023
- Application Sponsor Due Date (by invitation) - September 29, 2023
Description:
AstraZeneca and Breast Cancer Canada have united their efforts to provide two collaborative grants aimed at advancing research in breast cancer screening and detection. To bolster this collaboration, Illumina will contribute to the cause by generously offering in-kind donations of sequencing consumables.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.
ROADS: For more information and to apply, please contact Beatrice Fletcher, Senior Advisor.